FDA Inspection 1059965 — Institute for Reproductive Medicine and Science at Saint Barnabas, P.A.

Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. — FEI 3001047110

The FDA completed an inspection of Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. on July 19, 2018 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Livingston, NJ (United States)